Home Pilots GrayMatters Health receives FDA 510(k) for PTSD neuromodulation therapy Pilots GrayMatters Health receives FDA 510(k) for PTSD neuromodulation therapy By - March 27, 2023 54 0 Facebook Twitter Pinterest WhatsApp The company’s product, Prism, uses neurofeedback to help PTSD patients learn to control their emotional response. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Digital health tech company Huma scores $80M and more digital health raises Pilots - July 16, 2024 0 DEA alleges Truepill illegally dispensed thousands of prescription stimulants Pilots - December 19, 2022 0 Latest health IT integrations by Personify Care, Core Schedule and more briefs Pilots - July 22, 2024 0 Southeast Asian insurtech player Igloo gets $27M more in Series B funding Pilots - November 30, 2022 0 PointClickCare snaps up health IT company Audacious Inquiry Pilots - February 1, 2022 0 POPULAR CATEGORIESPilots2166Applications750Testing283Collaborations15GitHub3